Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 5, 2024

Primary Completion Date

June 5, 2026

Study Completion Date

June 5, 2029

Conditions
B-cell Acute Lymphoblastic Leukemia
Trial Locations (10)

100000

RECRUITING

Peking University People's Hospital, Beijing

RECRUITING

Peking University Third Hospital, Beijing

Unknown

RECRUITING

Zhujiang Hospital of Southern Medical University, Guangzhou

RECRUITING

Henan Cancer Hospital Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou

RECRUITING

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

RECRUITING

The Affiliated Hospital of Xuzhou Medical University, Xuzhou

RECRUITING

Qilu Hospital of Shandong university, Jinan

RECRUITING

Tongji Hospital of Tongji University, Shanghai

RECRUITING

West China School of Medicine/West China Hospital of Sichuan University, Chengdu

RECRUITING

Institute of Hematology & Blood Diseases Hospital, Tianjin

Sponsors
All Listed Sponsors
lead

Juventas Cell Therapy Ltd.

INDUSTRY